# Revolution Medicines shares promising data around KRAS drug combination

> **Open Intelligence Dossier** · First detected: 2026-07-03 23:07 UTC · Category: Business

## Executive Summary
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
"Revolution Medicines shares promising data around KRAS drug combination" is generating significant coverage in the Business category, with 5 articles from 5 distinct sources tracked by PULSE so far.


Outlets currently covering the story include Oncodaily, Medscape, Yahoo Finance and WSAW. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| Oncodaily | Anirban Maitra։ Data on Zoldonrasib Plus Daraxonrasib in 2nd and 3rd Line Metastatic Pancreatic Cancer | [Source Link](https://news.google.com/rss/articles/CBMiX0FVX3lxTE43dXRWUlc0a2puVklqX1ViMkhfVndxX3VNanJma0l2QjAyUXZWd2JSQUc1d3Y2dkNoS1Z4eG04Y0djdGszenh4LXhhRV9SYkFfNU5SMF9FSXFRM3BKUGFB?oc=5) |
| Medscape | Practice-Changing Data in GI Oncology | [Source Link](https://news.google.com/rss/articles/CBMiqwFBVV95cUxQbWNPM21aYmJhTVgxVzFFTFlXVl8xSUswT0dsaGY3TkZFNjlrb1kySTh6MjNURUxpcVlvNGtjRW9IUi1fZi1odExpd0E0OUg4aTN6ZkdHRkZxaDVpRTgtWUpZY2FjY1M5NHg0MjRWd2YxYm1DTzJ0SENDalZjUGd0MGFKYU1MUFpnUURSRWFYb0c2VVNKRnBrOTNEQmQzNXRwTG5pWTZxdmxORW8?oc=5) |
| Yahoo Finance | Revolution Medicines Presents Phase 1/2 Clinical Data for Zoldonrasib Combination Regimens in Patients with RAS G12D Metastatic Pancreatic Cancer at ESMO Gastrointestinal Cancers Congress 2026 | [Source Link](https://news.google.com/rss/articles/CBMinwFBVV95cUxOQXVBRnJqcU5sS21KejFhTUNMZmZjTEVxZWNkeXoxUHlWQlVSblF4OTVSSXA4R0stN3pvUGpMRHoxeWtyd1FzTjdTQTUwN245RGFKSS1kUUxQczlsQmFyNjk1a2xTVGFlZjY2UUxka0VBX2FraS1jbEtWU2tEX2xxa0dsWnpDMjRUeTYxc1RwNDI5Q1hrcGlmNmY0b3dybnc?oc=5) |
| WSAW | Experimental cancer drug brings time and hope for patients | [Source Link](https://news.google.com/rss/articles/CBMiiwFBVV95cUxNSHVUV2NGQkswTkgxYVQwd1hNMUp6Q2JvcFB6OGo0Z2xNWlJDY1FWNlc1OHdKcndGWkJlV2dxcHlwQ1pBQm8wZ1lpNUdtSDR2LTM4UndBWW1nckVsNzRUb0plM2xwVVpfbjh0bnFTalo3M2Z0RFlpaUpQTmI1V3F0SEpYUTBFY0xWYWFF0gGfAUFVX3lxTE5GNE5kOWNHY1RlZXhPOHl3ZjYtamZHRTJsVTY2N2lIQW45akhyOHlzeGt1c0JadHQ0dmlQTkFZLURJVU1FeGp1cktnQWJiUE90TXlZRWY3ZGRyOGgwWWphdXhESDhLaXE1c1ZKa1BuTkhmY1IwZW9KbGpjdWdTT2NVSURLSGt6WHBjenNHMkhHMUQ0RzFYNE1DcFJoMkp1SQ?oc=5) |
| Endpoints News | Revolution Medicines shares promising data around KRAS drug combination | [Source Link](https://news.google.com/rss/articles/CBMimwFBVV95cUxNV3hNVTN4WGlYb0pPOGQzSDlLNHE0REUtQ0dScU9YMkNWb2d6bDJPakpmckFzY01UTWlsRE5Rcm05MFZoYmh4ZkhZLTNNN1FyZ3lNTVdQZERadFpQbUJ6LTJ4dWtDNVk5NjA1T0xJckc0YWsxMzR1SkZZTUtvd1lLLW1nN0NpdmRIdERjQmtIQV9fajVxd1N1dDdJcw?oc=5) |

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-07-03/revolution-medicines-shares-promising-data-around-kras-drug-combination*